Stay updated on Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FfE-O5KLoDK4DkNGsPejBL3V5fjc.uncropped.jpg&w=3840&q=75)
Latest updates to the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.4%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study record details of the clinical trial for Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID. The revision reflects the latest information and updates made to the study record.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.SummaryDifference0.1%
- Check32 days agoChange DetectedThe recent change in the web page value from 'Show more Show more Revision: v2.9.0' to 'Show less MedlinePlus Genetics related topics: Adenosine deaminase deficiency MedlinePlus related topics: Genes and Gene Therapy Stem Cells Genetic and Rare Diseases Information Center resources: Severe Combined Immunodeficiency Adenosine Deaminase Deficiency Drug Information available for: Busulfan FDA Drug and Device Resources' represents an update in the content displayed on the page, providing detailed information on genetics, related topics, and resources for Severe Combined Immunodeficiency and Adenosine Deaminase Deficiency.SummaryDifference21%
Stay in the know with updates to Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety OTL-101 Cryopreserved ADA-SCID Clinical Trial page.